1 Rabe E, Pannier F, Bromen K, Schuldt K, Stang A, Poncar C, et al. Bonn Vein Study by German Society of Phlebology: Epidemiological study to investigate the prevalence and severity of chronic venous disorders in the urban and rural residential populations. Phlebologie. 2002;32:1–14.
2 Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh vein study. J Epidemiol Health. 1999;53:149–53.
3 Kern P, Ramelet AA, Küpfer S, Cassina P, Enzler M, Mahler F. Therapie der Varizen und Besenreiser der unteren Extremität: Medizinische und ästhetische Indikation. Schweiz Ärzteztg. 2004;85:2070–1.
4 Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for greater saphenous veins. Br J Surg. 2011;98:1079–87.
5 Nesbitt C, Bedenis R, Bhattacharya V. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2014;cd005624.
6 Gloviczki P, Comerota AJ, Dalsinf MC, Eklof BG, Gillespie DL, Gloviczki ML, et al.; Society of Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(Suppl):2S–48S.
7 Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, et al.: Management of Chronic Venous Disease. Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49:678–737.
8 Spinedi L, Broz P, Engelberger RP, Staub D, Uthoff H. Clinical and duplex ultrasound evaluation of lower extremities varicose veins – a practical guideline. Vasa. 2017;46:325–36.
9 García-Gimeno M, Rodríguez-Camarero S, Tagarro-Villalba S, Ramalle-Gomara, González-González E, González Arranz MA, et al. Duplex mapping of 2036 primary varicose veins. J Vasc Surg. 2009;49:681–9.
10 Tjeertes EK, Hoeks SE, Beks SB, Valentin TM, Hoofwijk AG, Stolker RJ. Obesity – a risk factor for postoperative complications in general surgery? BMC Anesthesiol. 2015;15:112.
11 Hayden A, Holdsworth J. Complications following re-exploration of the groin for recurrent varicose veins. Ann R Coll Surg Engl. 2001;83:272–3.
12 de Mik SML, Stubenrouch FE, Legemate, DA, Balm R, Ubbink DT, on behalf of the DISCOVAR study group. Treatment of varicose veins, international consensus on which major complications to discuss with the patient: A Delphi study. Phlebology. 2019;34:201–7.
13 Eklof B, Rutherford RB, Bergan JJ, Carpentier OH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.
14 Shami SK, Sarin S, Cheatle TR, Scurr JH, Coleridge Smith PD. Venous ulcers and the superficial venous system. J Vasc Surg. 1993;17:487–90.
15 Blättler W, Mendoza E, Zollmann C, Bendix J, Amsler F. Homeostatic feelings – a novel explanation of vein symptoms derived from an experimental patient study. Vasa. 2019;48:492–501.
16 Zöller B, Ji J, Sundquist J, Sundquist K. Venous thromboembolism and varicose veins share familial susceptibility: a nationwide family study in Sweden. J Am Heart Assoc. 2014;26:3.
17 Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al. (CALISTO Study Group). Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363:1222–32.
18 Beyer-Westendorf J, Schellong SM, Gerlach H, Rabe E, Weitz JI, Jersemann K, et al. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol. 2017;4:e105-e113.
19 Decousus H, Quere I, Presles E, et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152:218–24.
20 Rabe E, Partsch H, Hafner J, Lattimer C, Mosti G, Neumann M, et al. Indications for medical compression stockings in venous and lymphatic disorders: an evidence-based consensus statement. Phlebology. 2018;33(3):163–84.
21 Barwell JR, Davies CE, Deacon J, Harvey K, Minor J, Sassano A, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet. 2004;363(9424):1854–9.
22 Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, et al. (EVRA Trial Investigators). A randomized controlled trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018;378:2105–14.
23 Darvall KAL, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg. 2011;42:107–14.
24 Kulkarni SR, Slim FJA, Emerson LG, Davies C, Bulbulia RA, Whyman MR, et al. Effect of foam slcerotherapy on healing and long-term recurrence in chronic venous leg ulcers. Phlebology. 2013;28:140–6.
25 Müller-Bühl U, Leutgeb R, Bungartz J, Szecsenyi J, Laux G. Expenditure of chronic venous leg ulcer management in German primary care: results from a population-based study. Int Wound J. 2013;10:52–6.
26 Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N. Burden of venous leg ulcers in the United States. J Med Econ. 2014;17:347–56.